<--- Back to Details
First PageDocument Content
Organochlorides / Anagrelide / Lactams / Thrombocytosis / Polycythemia vera / Aspirin / Methadone / Megakaryocyte / Essential thrombocytosis / Medicine / Chemistry / Organic chemistry
Date: 2011-12-02 14:39:35
Organochlorides
Anagrelide
Lactams
Thrombocytosis
Polycythemia vera
Aspirin
Methadone
Megakaryocyte
Essential thrombocytosis
Medicine
Chemistry
Organic chemistry

AGRYLIN® (anagrelide hydrochloride) Capsules Rx only

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 99,87 KB

Share Document on Facebook

Similar Documents

NOMINATION FORM FOR MPN HEROES  NOMINATION FORM FOR MPN HEROES

NOMINATION FORM FOR MPN HEROES NOMINATION FORM FOR MPN HEROES

DocID: 1oHQS - View Document

1  Dr Jürgen Thiele Institute for Pathology University of Cologne Kerpener Str. 62

1 Dr Jürgen Thiele Institute for Pathology University of Cologne Kerpener Str. 62

DocID: 1ohLr - View Document

1  Dr James Vardiman Professor Emeritus Department of Pathology University of Chicago

1 Dr James Vardiman Professor Emeritus Department of Pathology University of Chicago

DocID: 1o8ES - View Document

Registered PM (EN) 09-Mar-2015: Administrative NDS - Company name change (New 3D version to include the Submission Control No)

Registered PM (EN) 09-Mar-2015: Administrative NDS - Company name change (New 3D version to include the Submission Control No)

DocID: 1lIPi - View Document

Phase 2 trial of PRM-151, an anti-fibrotic agent, in patients with myelofibrosis: Stage 1 results Srdan Verstovsek1, Ruben Mesa2, Lynda Foltz3, Vikas Gupta4, John Mascarenhas5, Ellen Ritchie6, Ronald Hoffman5, Richard

Phase 2 trial of PRM-151, an anti-fibrotic agent, in patients with myelofibrosis: Stage 1 results Srdan Verstovsek1, Ruben Mesa2, Lynda Foltz3, Vikas Gupta4, John Mascarenhas5, Ellen Ritchie6, Ronald Hoffman5, Richard

DocID: 19YPO - View Document